{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T07:03:32Z","timestamp":1769583812002,"version":"3.49.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,15]]},"DOI":"10.7759\/cureus.87984","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:15:46Z","timestamp":1752585346000},"source":"Crossref","is-referenced-by-count":2,"title":["Bisphosphonate-Induced Atypical Femoral Fractures in Pediatric Patients With Lipoprotein Receptor-Related Protein 5 (LRP5) Gene Mutation: A Case Report of Twin Patients"],"prefix":"10.7759","author":[{"given":"Mohamed","family":"Sarhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustafa","family":"Aly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Humphry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10024","article-title":"Genetic risk factors for atypical femoral fractures (AFFs): a systematic review","volume":"2","author":"Nguyen HH","year":"2018","unstructured":"Nguyen HH, van de Laarschot DM, Verkerk AJ, Milat F, Zillikens MC, Ebeling PR. Genetic risk factors for atypical femoral fractures (AFFs): a systematic review. JBMR Plus. 2018, 2:1-11. 10.1002\/jbm4.10024","journal-title":"JBMR Plus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10741","article-title":"Lrp5 p.Val667Met variant compromises bone mineral density and matrix properties in osteoporosis","volume":"7","author":"Fabre S","year":"2023","unstructured":"Fabre S, Bourmaud M, Mabilleau G, et al.. Lrp5 p.Val667Met variant compromises bone mineral density and matrix properties in osteoporosis. JBMR Plus. 2023, 7:e10741. 10.1002\/jbm4.10741","journal-title":"JBMR Plus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-13-26","article-title":"Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity","volume":"13","author":"Korvala J","year":"2012","unstructured":"Korvala J, J\u00fcppner H, M\u00e4kitie O, et al.. Mutations in LRP5 cause primary osteoporosis without features of OI by reducing Wnt signaling activity. BMC Med Genet. 2012, 13:26. 10.1186\/1471-2350-13-26","journal-title":"BMC Med Genet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152833","article-title":"Critical endothelial regulation by LRP5 during retinal vascular development","volume":"11","author":"Huang W","year":"2016","unstructured":"Huang W, Li Q, Amiry-Moghaddam M, et al.. Critical endothelial regulation by LRP5 during retinal vascular development. PLoS One. 2016, 11:e0152833. 10.1371\/journal.pone.0152833","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116289","article-title":"Bisphosphonates: the role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use","volume":"156","author":"Ebetino FH","year":"2022","unstructured":"Ebetino FH, Sun S, Cherian P, et al.. Bisphosphonates: the role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use. Bone. 2022, 156:116289. 10.1016\/j.bone.2021.116289","journal-title":"Bone"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115493","article-title":"Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton","volume":"139","author":"Rogers MJ","year":"2020","unstructured":"Rogers MJ, M\u00f6nkk\u00f6nen J, Munoz MA. Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton. Bone. 2020, 139:115493. 10.1016\/j.bone.2020.115493","journal-title":"Bone"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.35366\/113960","article-title":"Atypical femoral fractures due to the use of bisphosphonates. Experience of two institutions (Article in Spanish)","volume":"5","author":"Villegas RI","year":"2024","unstructured":"Villegas RI, Melo-Dur\u00e1n S, Cevallos A, et al.. Atypical femoral fractures due to the use of bisphosphonates. Experience of two institutions (Article in Spanish). Acta Ortop\u00e9dica Mexicana. 2024, 5:270-5. 10.35366\/113960","journal-title":"Acta Ortop\u00e9dica Mexicana"},{"key":"ref8","article-title":"Bisphosphonate associated atypical femur fracture and contralateral impending atypical femur fracture in a pediatric patient with osteogenesis imperfecta: a case report","volume":"10","author":"Albertson B","year":"2021","unstructured":"Albertson B, Polander T, Silva S. Bisphosphonate associated atypical femur fracture and contralateral impending atypical femur fracture in a pediatric patient with osteogenesis imperfecta: a case report. WJO. 2021, 10:16.","journal-title":"WJO"},{"key":"ref9","unstructured":"SLIM\u2122 - Simple Locking IntraMedullary System. (2018). Accessed. June 6, 2025: https:\/\/www.orthopediatrics.com\/products\/slim-simple-locking-intramedullary-system-pega-orthopediatrics\/."},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-87950-1_27","article-title":"Atypical femur fractures","author":"El Miedany Y","year":"2022","unstructured":"El Miedany Y. Atypical femur fractures. New Horizons in Osteoporosis Management. Springer, Cham; 2022. 715-34. 10.1007\/978-3-030-87950-1_27"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11914-021-00658-y","article-title":"The genetics of atypical femur fractures\u2014a systematic review","volume":"19","author":"Zhou W","year":"2021","unstructured":"Zhou W, van Rooij JG, Ebeling PR, Verkerk AJ, Zillikens MC. The genetics of atypical femur fractures\u2014a systematic review. Curr Osteoporos Rep. 2021, 19:123-30. 10.1007\/s11914-021-00658-y","journal-title":"Curr Osteoporos Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3745","article-title":"Bisphosphonate treatment and the characteristics of femoral fractures in children with osteogenesis imperfecta","volume":"102","author":"Vuorimies I","year":"2017","unstructured":"Vuorimies I, M\u00e4yr\u00e4np\u00e4\u00e4 MK, Valta H, Kr\u00f6ger H, Toiviainen-Salo S, M\u00e4kitie O. Bisphosphonate treatment and the characteristics of femoral fractures in children with osteogenesis imperfecta. J Clin Endocrinol Metab. 2017, 102:1333-9. 10.1210\/jc.2016-3745","journal-title":"J Clin Endocrinol Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.4801","article-title":"Prevalence of monogenic bone disorders in a Dutch cohort of atypical femur fracture patients","volume":"38","author":"Zhou W","year":"2023","unstructured":"Zhou W, van Rooij JG, van de Laarschot DM, et al.. Prevalence of monogenic bone disorders in a Dutch cohort of atypical femur fracture patients. J Bone Miner Res. 2023, 38:896-906. 10.1002\/jbmr.4801","journal-title":"J Bone Miner Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25042321","article-title":"High frequencies of genetic variants in patients with atypical femoral fractures","volume":"25","author":"Del Real \u00c1","year":"2024","unstructured":"Del Real \u00c1, Cruz R, Sa\u00f1udo C, et al.. High frequencies of genetic variants in patients with atypical femoral fractures. Int J Mol Sci. 2024, 25:2321. 10.3390\/ijms25042321","journal-title":"Int J Mol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2021.116297","article-title":"Bisphosphonates and the risk of atypical femur fractures","volume":"156","author":"Black DM","year":"2022","unstructured":"Black DM, Condra K, Adams AL, Eastell R. Bisphosphonates and the risk of atypical femur fractures. Bone. 2022, 156:116297. 10.1016\/j.bone.2021.116297","journal-title":"Bone"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-024-00652-2","article-title":"Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures","volume":"18","author":"Garcia-Giralt N","year":"2024","unstructured":"Garcia-Giralt N, Ovejero D, Grinberg D, Nogues X, Casta\u00f1eda S, Balcells S, Rabionet R. Assessing the contribution of genes involved in monogenic bone disorders to the etiology of atypical femoral fractures. Hum Genomics. 2024, 18:87. 10.1186\/s40246-024-00652-2","journal-title":"Hum Genomics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/375539-bisphosphonate-induced-atypical-femoral-fractures-in-pediatric-patients-with-lipoprotein-receptor-related-protein-5-lrp5-gene-mutation-a-case-report-of-twin-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:15:47Z","timestamp":1752585347000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/375539-bisphosphonate-induced-atypical-femoral-fractures-in-pediatric-patients-with-lipoprotein-receptor-related-protein-5-lrp5-gene-mutation-a-case-report-of-twin-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.87984","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7,15]]}}}